A. Bobik

发表

Toll‐Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells

K. Peter, P. Tipping, H. Hosseini, 2016, Journal of the American Heart Association.

B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions

P. Tipping, A. Agrotis, B. Toh, 2011, Circulation research.

Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation

P. Tipping, H. Hosseini, B. Toh, 2012, PloS one.

Alternative splicing within the TGF‐β type I receptor gene (ALK‐5) generates two major functional isoforms in vascular smooth muscle cells

M. Condron, A. Agrotis, A. Bobik, 2000, FEBS letters.

Spontaneous oscillations in cytoplasmic calcium concentration in vascular smooth muscle.

P. Weissberg, P. Little, A. Bobik, 1989, The American journal of physiology.

Transforming Growth Factor-&bgr;s and Vascular Disorders

A. Bobik, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques

A. Murphy, K. Peter, I. Ahrens, 2009, Circulation research.

Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets

K. Peter, C. Hagemeyer, P. Kanellakis, 2016, Scientific Reports.

Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

S. Akira, M. Sweet, K. Peter, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice

M. Febbraio, G. Lancaster, C. Bruce, 2011, Diabetologia.

Striatin-dependent membrane estrogen receptor signaling and vasoprotection by estrogens.

A. Bobik, 2012, Circulation.

Killer cells in atherosclerosis

P. Tipping, B. Toh, A. Bobik, 2017, European journal of pharmacology.

Immune regulation by CD52-expressing CD4 T cells

P. Tipping, B. Toh, A. Bobik, 2013, Cellular and Molecular Immunology.

Experimental Rupture of Atherosclerotic Lesions Increases Distal Vascular Resistance: A Limiting Factor to the Success of Infarct Angioplasty

Andrew J Taylor, G. Jennings, A. Bobik, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Metalloproteinases and plasminogen activators in vessel remodeling

A. Bobik, V. Tkachuk, 2003, Current hypertension reports.

Timolol pharmacokinetics and effects on heart rate and blood pressure after acute and chronic administration

P. Ashley, P. Korner, G. Jennings, 1979, European Journal of Clinical Pharmacology.

Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.

P. Korner, G. Jennings, A. Bobik, 1981, British journal of clinical pharmacology.

COMPARISON OF EFFECTIVENESS OF TIMOLOL ADMINISTERED ONCE A DAY AND TWICE A DAY IN THE CONTROL OF BLOOD PRESSURE IN ESSENTIAL HYPERTENSION

P. Korner, G. Jennings, A. Bobik, 1979, The Medical journal of Australia.

Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.

P. Korner, G. Jennings, A. Bobik, 1979, British journal of clinical pharmacology.

DIFFERENTIAL REGULATION BY TRANSFORMING GROWTH FACTOR‐β1 OF PLATELET‐DERIVED GROWTH FACTOR‐ STIMULATED PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS FROM SHR AND WKY RATS

A. Agrotis, A. Bobik, J. Saltis, 1992, Clinical and experimental pharmacology & physiology.

EFFECT OF TRANSFORMING GROWTH FACTOR‐β1 ON PLATELET‐DERIVED GROWTH FACTOR RECEPTOR BINDING AND GENE EXPRESSION IN VASCULAR SMOOTH MUSCLE CELLS FROM SHR AND WKY RATS

A. Agrotis, A. Bobik, J. Saltis, 1994, Clinical and experimental pharmacology & physiology.

Developmental regulation of transforming growth factor-β1 responses and vascular smooth muscle growth in spontaneously hypertensive rats

A. Bobik, J. Saltis, 1995, Journal of hypertension.

Cytotoxic and Proinflammatory CD 8 + T Lymphocytes Promote Development of Vulnerable Atherosclerotic Plaques in ApoE-/-Mice Running title :

P. Tipping, H. Hosseini, B. Toh, 2013 .

Cytotoxic and Proinflammatory CD8+ T Lymphocytes Promote Development of Vulnerable Atherosclerotic Plaques in ApoE-Deficient Mice

P. Tipping, H. Hosseini, B. Toh, 2013, Circulation.

Back Matter

Bates, R. H. Ritchie, M. E. Coupland, 1999 .

INHIBITORS OF HEPATIC MIXED FUNCTION OXIDASE. 3. INHIBITION OF HEPATIC MICROSOMAL ANILINE HYDROXYLASE AND AMINOPYRINE DEMETHYLASE BY 2,6- AND 2,4-DIHYDROXYPHENYL ALKYL KETONES AND RELATED COMPOUNDS

G. Holder, A. Bobik, A. J. Ryan, 1977 .

Vascular growth responses in SHR and WKY during development of renal (1K1C) hypertension.

J. Bertram, R. Dilley, M. Black, 1997, American journal of hypertension.

Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth.

P. Little, A. Bobik, E. Cragoe, 1991, The American journal of physiology.

MULTIPLE GROWTH ABNORMALITIES IN VASCULAR SMOOTH MUSCLE FROM SPONTANEOUSLY HYPERTENSIVE RATS

P. Little, A. Bobik, J. Saltis, 1991, Clinical and experimental pharmacology & physiology.

Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.

K. Peter, A. Kallies, B. Toh, 2020, European heart journal.

Determination of norepinephrine apparent release rate and clearance in humans.

P. Korner, G. Jennings, M. Esler, 1979, Life sciences.

Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats.

P. Korner, A. Bobik, Alex Bobik, 1995, Hypertension.

Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease.

Andrew J Taylor, G. Jennings, D. Kaye, 2004, American heart journal.

Vascular types I and II transforming growth factor‐beta receptor expression: differential dependency on tyrosine kinases during induction by TGF‐β

M. Ward, G. Jennings, A. Agrotis, 1998, FEBS letters.

Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.

M. Ward, G. Jennings, R. Dilley, 1997, Arteriosclerosis, thrombosis, and vascular biology.

VASCULAR REMODELLING AND MOLECULAR BIOLOGY: NEW CONCEPTS AND THERAPEUTIC POSSIBILITIES

A. Agrotis, A. Bobik, Alex Agrotis, 1996, Clinical and experimental pharmacology & physiology.

REGULATION AND INTERACTIONS OF TRANSFORMING GROWTH FACTOR‐β WITH CARDIOVASCULAR CELLS: IMPLICATIONS FOR DEVELOPMENT AND DISEASE

A. Agrotis, A. Bobik, J. Saltis, 1996, Clinical and experimental pharmacology & physiology.

Hypertension, transforming growth factor-beta, angiotensin II and kidney disease.

A. Bobik, 2004, Journal of hypertension.

Hypertension, transforming growth factor- , angiotensin II and kidney disease

A. Bobik, 2004 .

Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.

N. Kalinina, A. Agrotis, P. Kanellakis, 2004, Arteriosclerosis, thrombosis, and vascular biology.

PINDOLOLPHARMACOKINETICS INRELATIONTO TIMECOURSE OF INHIBITION OF EXERCISETACHYCARDIA

G. Jennings, A. Bobik, E. T. Fagan, 1979 .

A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.

P. Tipping, H. Hosseini, B. Toh, 2016, Cardiovascular research.

Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines

N. Kalinina, A. Agrotis, P. Kanellakis, 2004 .

Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats.

A. Agrotis, A. Bobik, J. Saltis, 1994, Hypertension.

AGE‐DEPENDENT ALTERATIONS IN VASCULAR SMOOTH MUSCLE CELL RESPONSIVENESS TO PLATELET‐DERIVED GROWTH FACTOR IN GENETIC HYPERTENSION

A. Agrotis, A. Bobik, J. Saltis, 1993, Clinical and experimental pharmacology & physiology.

Follicular B Cells Promote Atherosclerosis via T Cell–Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G

P. Tipping, A. Kallies, H. Hosseini, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Relation of local platelet glycoprotein IIb/IIIa independent activation during coronary angioplasty in acute myocardial infarction to recovery of left ventricular function.

G. Jennings, A. Bobik, V. Kalff, 2003, The American journal of cardiology.

Role of autoinhibitory feedback in cardiac sympathetic transmission.

P. Korner, I. Kopin, J. Angus, 1984, Clinical and experimental hypertension. Part A, Theory and practice.

Bioavailability of dihydroergotamine in man.

G. Jennings, P. Little, A. Bobik, 1982, British journal of clinical pharmacology.

GUANETHIDINE‐INDUCED VASODILATATION IN THE RABBIT, MEDIATED BY ENDOGENOUS HISTAMINE

P. Korner, J. Angus, A. Bobik, 1978, British journal of pharmacology.

Response to balloon injury is vascular bed specific: a consequence of de novo vessel structure?

M. Ward, G. Jennings, P. Kanellakis, 2000, Atherosclerosis.

Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension.

A. Agrotis, P. Kanellakis, A. Bobik, 2000, Hypertension.

The structural basis of hypertension: vascular remodelling, rarefaction and angiogenesis/arteriogenesis.

A. Bobik, 2005, Journal of hypertension.

Low Blood Flow After Angioplasty Augments Mechanisms of Restenosis: Inward Vessel Remodeling, Cell Migration, and Activity of Genes Regulating Migration

P. Tsao, M. Ward, G. Jennings, 2001, Arteriosclerosis, thrombosis, and vascular biology.

A causal role of C-reactive protein (CRP) in inflammation: Conformational rearrangement in C-reactive protein is required for enhanced pro-inflammatory leukocyte activation and leukocyte adhesion in ischemiareperfusion of the striated muscle

A. Murphy, K. Peter, J. Chin-Dusting, 2009 .

HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi

M. Sweet, K. Peter, I. Ahrens, 2015, Thrombosis and Haemostasis.

Obligatory Role for B Cells in the Development of Angiotensin II–Dependent Hypertension

K. Peter, C. Sobey, P. Tipping, 2015, Hypertension.

RATE OF REMOVAL OF NOREPINEPHRINE FROM THE CIRCULATION IN HEALTHY MEN AND PATIENTS WITH ESSENTIAL HYPERTENSION

P. Korner, G. Jennings, M. Esler, 1979 .

Chapter 71 – Atherosclerosis

P. Tipping, B. Toh, A. Bobik, 2014 .

Analysis of milrinone in plasma using solid-phase extraction and high-performance liquid chromatography.

G. Jackman, A. Bobik, C. Oddie, 1986, Journal of chromatography.

Growth factor activity of endothelin on vascular smooth muscle.

A. Bobik, A. Mitchell, J. Millar, 1990, The American journal of physiology.

Inhibitors of hepatic mixed function oxidase. 3. Inhibition of hepatic microsomal aniline hydroxylase and aminopyrine demethylase by 2,6- and 2,4-dihydroxyphenyl alkyl ketones and related compounds.

G. Holder, A. Bobik, A. J. Ryan, 1977, Journal of medicinal chemistry.

Effects of 5,6‐Dihydroxytryptamine on the Release, Synthesis, and Storage of Serotonin: Studies Using Rat Brain Synaptosomes

A. Bobik, W. Wolf, 1988, Journal of neurochemistry.

Expression of growth factor receptors in arterial smooth muscle cells. Dependency on cell phenotype and serum factors.

J. Campbell, A. Agrotis, A. Bobik, 1995, Atherosclerosis.

VASCULAR SMOOTH MUSCLE CELL PROLIFERATION IN SHR AND WKY RATS: EVIDENCE FOR SPECIFIC DIFFERENCES IN GROWTH INHIBITORY REGULATORY MECHANISMS

A. Agrotis, A. Bobik, P. Bray, 1993, Clinical and experimental pharmacology & physiology.

TGF-beta 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension.

A. Agrotis, A. Bobik, J. Saltis, 1992, The American journal of physiology.

Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.

G. Jennings, R. Dilley, A. Agrotis, 1997, Circulation.

Relationship Between KCa Channel Diversity and Smooth Muscle Cell Function

P. Reinhart, A. Bobik, R. Lang, 1999 .

Molecular Cloning and Characterization of the Intermediate-Conductance Ca2+-Activated K+ Channel in Vascular Smooth Muscle

P. Reinhart, A. Bobik, R. Lang, 1999 .

Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function.

P. Reinhart, A. Bobik, R. Lang, 1999, Circulation research.

Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation.

M. Febbraio, G. Fingerle-Rowson, R. Bucala, 2011, Journal of molecular and cellular cardiology.

Transforming growth factor-beta 1 and the development of vascular hypertrophy in hypertension.

R. Dilley, A. Agrotis, A. Bobik, 1995, Blood pressure. Supplement.

Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat

Julie H. Campbell, J. Campbell, M. Adams, 1989, Journal of hypertension.

Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis

P. Tipping, B. Toh, A. Bobik, 2011, Current opinion in lipidology.

Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.

Xiaojun Du, P. Kanellakis, A. Bobik, 2006, Cardiovascular research.

Hematopoietic Cell–Restricted Deletion of CD36 Reduces High-Fat Diet–Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue

M. Febbraio, A. Bonen, M. Watt, 2011, Diabetes.

Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: new players in human atherogenesis.

N. Kalinina, A. Bobik, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Pharmacological considerations in digoxin therapy

A. Bobik, 1993, The Medical journal of Australia.

hypertension. Relation to sympathetic function Differential development of vascular and cardiac hypertrophy in genetic

M. Adams, A. Bobik, P. Korner, 2011 .

Sympathoadrenal system is critical for structural changes in genetic hypertension.

P. Korner, P. Friberg, A. Bobik, 1993, Hypertension.

Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle.

P. Little, G. Jackman, A. Bobik, 1990, Biochemical and biophysical research communications.

Differential Development of Vascular and Cardiac Hypertrophy in Genetic Hypertension Relation to Sympathetic Function

M. Adams, A. Bobik, P. Korner, 1989, Hypertension.

EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE CARDIOVASCULAR AMPLIFIERS

P. Korner, G. Jennings, M. Adams, 1988, Clinical and experimental pharmacology & physiology.

Apolipoprotein Ciii and Atherosclerosis beyond Effects on Lipid Metabolism Editorial

A. Bobik, Alex Bobik, 2022 .

REGULATION OF SODIUM INFLUX AND SODIUM, POTASSIUM PUMP ACTIVITY BY A SODIUM‐HYDROGEN ANTIPORT IN RAT VASCULAR SMOOTH MUSCLE

P. Weissberg, P. Little, A. Bobik, 1987, Clinical and experimental pharmacology & physiology.

Na-H exchange is a major pathway for Na influx in rat vascular smooth muscle.

P. Little, A. Bobik, E. Cragoe, 1986, The American journal of physiology.

Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet

S. Subramanian, A. Chait, M. Nishibori, 2015, Nutrition & Diabetes.

Determination of pindolol in human plasma by high-performance liquid chromatography.

G. Jackman, A. Bobik, M. Bangah, 1980, Journal of chromatography.

Na-H antiport in cultured rat aortic smooth muscle: its role in cytoplasmic pH regulation.

P. Weissberg, P. Little, A. Bobik, 1987, The American journal of physiology.

Influence of sympathectomy on alpha 2 adrenoceptor binding sites in canine blood vessels.

W. P. Anderson, A. Bobik, 1983, Life sciences.

Desensitization of the alpha1 adrenoceptor system in vascular smooth muscle

Julie H. Campbell, P. Little, A. Bobik, 1984 .

Darbepoetin‐mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor–common β‐chain heteroreceptor

Xiao-Ming Gao, Xiaojun Du, A. Agrotis, 2010, British journal of pharmacology.

Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.

M. Ward, G. Jennings, R. Dilley, 1998, Atherosclerosis.

Mechanism of Isoprenaline‐Induced Refractoriness of the β‐Adrenoceptor—Adenylate Cyclase Syste in Chick Embryo Cardiac Cells

J. Campbell, A. Bobik, G. Campbell, 1981, Journal of cardiovascular pharmacology.

Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury

K. Peter, J. Haigh, Xiao-Ming Gao, 2017, Theranostics.

Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.

P. Korner, G. Jennings, M. Esler, 1980, Clinical science.

LONG‐TERM ANGIOTENSIN II ANTAGONISM IN SPONTANEOUSLY HYPERTENSIVE RATS: EFFECTS ON BLOOD PRESSURE AND CARDIOVASCULAR AMPLIFIERS

R. Dilley, A. Bobik, C. Oddie, 1992, Clinical and experimental pharmacology & physiology.

Activation Transcription Factor-4 Induced by Fibroblast Growth Factor-2 Regulates Vascular Endothelial Growth Factor-A Transcription in Vascular Smooth Muscle Cells and Mediates Intimal Thickening in Rat Arteries Following Balloon Injury

L. Khachigian, P. Kanellakis, A. Bobik, 2008, Circulation research.

Multiple types of ryanodine receptor/Ca2+ release channels are expressed in vascular smooth muscle.

A. Agrotis, A. Bobik, C. Neylon, 1995, Biochemical and biophysical research communications.

Thrombin-induced Ca2+ mobilization in vascular smooth muscle utilizes a slowly ribosylating pertussis toxin-sensitive G protein. Evidence for the involvement of a G protein in inositol trisphosphate-dependent Ca2+ release.

V. Tkachuk, P. Little, A. Bobik, 1992, The Journal of biological chemistry.

CD4+ Natural Killer T Cells Potently Augment Aortic Root Atherosclerosis by Perforin- and Granzyme B-Dependent Cytotoxicity

P. Tipping, M. Smyth, H. Hosseini, 2015, Circulation research.

RAT AORTIC SMOOTH MUSCLE CELLS EXPRESSING CHARYBDOTOXIN‐SENSITIVE POTASSIUM CHANNELS EXHIBIT ENHANCED PROLIFERATIVE RESPONSES

A. Bobik, P. Avdonin, C. Neylon, 1994, Clinical and experimental pharmacology & physiology.

and Inhibit Allergic Airway Inflammation Modify Pulmonary Dendritic Cell Function Inert 50-nm Polystyrene Nanoparticles That

R. O’Hehir, M. Plebanski, Jun Yao, 2011 .

Role of Ca2+ in metabolic inhibition-induced norepinephrine release in rat brain synaptosomes.

A. Dart, M. Esler, P. Little, 1997, Circulation research.

Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.

A. Bobik, 1982, Life sciences.

Role of Cyclic AMP in Cardiac β‐Adrenoceptor Desensitization: Studies Using Prenalterol and Inhibitors of Phosphodiesterase

P. Little, A. Bobik, 1984, Journal of cardiovascular pharmacology.

Cardioselectivity of prenalterol and isoproterenol

P. Korner, A. Bobik, M. Hargreaves, 1983, Clinical pharmacology and therapeutics.

M1 macrophages, key contributors to lymphoid neogenesis in atherosclerotic aorta.

P. Tipping, B. Toh, A. Bobik, 2014, Cardiovascular research.

Age-dependence of noradrenaline kinetics in normal subjects.

P. Korner, M. Esler, G. Jackman, 1981, Clinical science.

Anti‐TIM‐1 Monoclonal Antibody (RMT1‐10) Attenuates Atherosclerosis By Expanding IgM‐producing B1a Cells

K. Peter, H. Hosseini, B. Toh, 2018, Journal of the American Heart Association.

Protective role of natural IgM-producing B1a cells in atherosclerosis.

P. Tipping, B. Toh, A. Bobik, 2012, Trends in cardiovascular medicine.

Aggravates Atherosclerosis Ameliorates whereas Its Adoptive Transfer Conventional B2 B Cell Depletion

P. Tipping, A. Agrotis, B. Toh, 2010 .

Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.

G. Jennings, M. Esler, G. Jackman, 1981, British journal of clinical pharmacology.

Opposing roles of B lymphocyte subsets in atherosclerosis

P. Tipping, B. Toh, A. Bobik, 2017, Autoimmunity.

Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol

G. Jennings, A. Bobik, C. Oddie, 1984, Clinical pharmacology and therapeutics.

Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture.

G. Jennings, A. Bobik, M. Berndt, 2004, European journal of pharmacology.

Antibodies in the Pathogenesis of Hypertension

C. Sobey, B. Toh, A. Bobik, 2014, BioMed research international.

Mechanical strain stimulates a mitogenic response in coronary vascular smooth muscle cells via release of basic fibroblast growth factor.

G. Jennings, P. Little, R. Dilley, 2001, American journal of hypertension.

B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation.

K. Peter, P. Tipping, H. Hosseini, 2016, Cardiovascular research.

Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.

M. Wehling, J. Funder, M. Fullerton, 1995, Circulation research.

Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries

P. Erne, V. Tkachuk, Y. Parfyonova, 2000, Journal of hypertension.

Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis

P. Tipping, A. Agrotis, B. Toh, 2012, Circulation.

Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types.

V. Tkachuk, R. Dilley, A. Bobik, 1994, Circulation research.

The pH of spontaneously beating cultured rat heart cells is regulated by an ATP-calmodulin-dependent Na+/H+ antiport.

P. Weissberg, P. Little, A. Bobik, 1989, Circulation research.

Significance of cardiovascular hypertrophy in the development and maintenance of hypertension.

P. Korner, G. Jennings, J. Angus, 1991, Journal of Cardiovascular Pharmacology.

The effects of alterations in membrane sodium transport on rat aortic smooth muscle proliferation

P. Little, A. Bobik, A. Grooms, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

High-performance liquid chromatographic determination of plasma catecholamines during α-methyldopa therapy

G. Jackman, A. Bobik, H. Skews, 1998 .

Effect of norepinephrine uptake blockers on norepinephrine kinetics

M. Esler, A. Bobik, P. Korner, 1981, Clinical pharmacology and therapeutics.

Simple and sensitive procedure for the assay of serotonin and catecholamines in brain by high-performance liquid chromatography using fluorescence detection.

G. Jackman, A. Bobik, H. Skews, 1980, Journal of chromatography.

Norepinephrine Kinetics in Patients with Idiopathic Autonomic Insufficiency

P. Korner, G. Jennings, M. Esler, 1980, Circulation research.

Evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes

B. Toh, A. Bobik, T. Kyaw, 2020, Expert opinion on therapeutic targets.

Circulating microparticles. Markers or participants in carotid artery remodelling?

A. Bobik, 2010, Journal of hypertension.

Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats

M. Black, P. Kanellakis, A. Bobik, 1997, Journal of hypertension.

Secretory phospholipase A2 type IIA: a regulator of immune function in atherosclerosis?

A. Bobik, 2009, Cardiovascular research.

Effects of noradrenergic neuronal activity on 3,4-dihydroxyphenylethylene glycol (DHPG) levels. Quantitation by high performance liquid chromatography.

G. Jackman, A. Bobik, J. Snell, 1982, Life sciences.

Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism.

H. Nilsson, M. Adams, P. Friberg, 1994, Kidney international.

NKT Cell Subsets Mediate Differential Proatherogenic Effects in ApoE−/− Mice

G. Besra, A. Agrotis, B. Toh, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle.

V. Tkachuk, P. Little, A. Bobik, 1992, Biochemical and biophysical research communications.

HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?

K. Peter, A. Bobik, 2012, Atherosclerosis.

Intracellular signalling pathways regulating vascular NAD(P)H oxidase and hypertension: an opportunity for development of novel antihypertensive agents?

A. Bobik, 2003, Journal of hypertension.

Cytokine Therapy with IL-2/anti-IL-2mAb Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and of Developed Atherosclerosis

P. Tipping, A. Agrotis, B. Toh, 2012 .

GM-CSF Deficiency Reduces Macrophage PPAR-&ggr; Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice

B. Toh, A. Bobik, M. Ditiatkovski, 2006, Arteriosclerosis, thrombosis, and vascular biology.

PLASMA PINDOLOL LEVELS AND THEIR SIGNIFICANCE IN THE ASSESSMENT OF CARDIAC BETA BLOCKADE

P. Korner, G. Jennings, A. Bobik, 1977, The Medical journal of Australia.

PINDOLOL: EXERCISE TESTING AND ANGINA

P. Korner, G. Jennings, A. Bobik, 1977, The Medical journal of Australia.

Urokinase Induces Matrix Metalloproteinase-9/Gelatinase B Expression in THP-1 Monocytes via ERK1/2 and Cytosolic Phospholipase A2 Activation and Eicosanoid Production

A. Vorotnikov, V. Tkachuk, B. Berk, 2006, Journal of Vascular Research.

Interaction between oral propranolol and hydralazine

A. Mclean, A. Bobik, F. Dudley, 1980, Clinical pharmacology and therapeutics.

Smooth Muscle Cell Types

V. Tkachuk, R. Dilley, A. Bobik, 2005 .

Investigation of cardiac beta-adrenoceptors using 125I-labelled 1-(4-iodophenoxy)-3-isopropylaminopropan-2-ol.

C. Johnston, E. Woodcock, J. Funder, 1978, European journal of pharmacology.

REGULATION BY PROTEIN KINASE C OF TRANSFORMING GROWTH FACTOR‐β1 ACTION ON THE PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS

A. Bobik, J. Saltis, 1996 .

An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis.

K. Peter, R. Srivastava, M. Hulett, 2022, Small.

Dependence of Na+/H+ antiport activation in cultured rat aortic smooth muscle on calmodulin, calcium, and ATP. Evidence for the involvement of calmodulin-dependent kinases.

P. Weissberg, P. Little, A. Bobik, 1988, The Journal of biological chemistry.

Cardiac β-Adrenoceptors and Adenylyl Cyclase Activity in Rabbit Heart during Conditions of Altered Sympathetic Activity

A. Bobik, V. Carson, J. Oliver, 1980, Circulation research.

Vascular derived growth factors: cell biology, pathophysiology, and pharmacology.

A. Bobik, J. Campbell, 1993, Pharmacological reviews.

ASSESSMENT OF NEURONAL UPTAKE OF NORADRENALINE IN HUMANS: DEFECTIVE UPTAKE IN SOME PATIENTS WITH ESSENTIAL HYPERTENSION

P. Korner, G. Jennings, M. Esler, 1980, Clinical and experimental pharmacology & physiology.

Low Tregs: A targetable risk factor for life‐threatening cardiovascular complications after major noncardiac surgery

A. Bobik, T. Kyaw, 2020, Journal of leukocyte biology.

Vascular Smooth Muscle Cells Express Multiple Type I Receptors for TGF-β,Activin, and Bone Morphogenetic Proteins ☆

A. Agrotis, A. Bobik, M. Samuel, 1996 .

Yin Yang‐1 Inhibits Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1‐Cdk4‐Cyclin D1 Assembly

L. Khachigian, P. Kanellakis, A. Bobik, 2007 .

Transforming Growth Factor-β, Cell Signaling and Cardiovascular Disorders

N. Kalinina, A. Agrotis, A. Bobik, 2005 .

Role of auto‐inhibitory feed‐back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H‐efflux and atrial rate in guinea‐pig atrium

P. Korner, I. Kopin, J. Angus, 1984, British journal of pharmacology.

Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts

K. Peter, B. Toh, P. Kanellakis, 2022, Frontiers in Immunology.

Adoptive Transfer Aggravates B Cell Depletion Ameliorates whereas Its Response to Comment on ''Conventional B2

P. Tipping, B. Toh, Christopher Tay, 2013 .

The role of urokinase in cell migration induced by growth factors

A. Bobik, V. Stepanova, S. Domogatskii, 1999, Bulletin of Experimental Biology and Medicine.

IONIC MECHANISMS REGULATING SODIUM ENTRY INTO VASCULAR SMOOTH MUSCLE

P. Little, A. Bobik, C. Neylon, 1991, Clinical and experimental pharmacology & physiology.

Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension.

P. Korner, G. Jennings, M. Esler, 1981, Clinical science.

Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms.

P. Tipping, B. Toh, P. Kanellakis, 2014, Cardiovascular research.

BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE−/− Mice

P. Tipping, A. Rolink, H. Hosseini, 2013, PloS one.

Excretory and metabolic studies of isopropyl N-(3-chlorophenyl)carbamate in the rat.

G. Holder, A. Bobik, A. J. Ryan, 1972, Food and cosmetics toxicology.

Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?

A. Bobik, T. Kyaw, 2021, Journal of hypertension.

Analysis of bopindolol and its active metabolite 18-502 in human plasma by high-performance liquid chromatography.

G. Jackman, A. Bobik, C. Oddie, 1983, Journal of chromatography.

Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.

A. Chait, P. Little, A. Bobik, 2011, Pharmacology & therapeutics.

Smad Expression in Human Atherosclerotic Lesions Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions

N. Kalinina, A. Agrotis, A. Bobik, 2004, Arteriosclerosis, thrombosis, and vascular biology.

High-performance liquid chromatographic analysis of norepinephrine and alpha-methylnorepinephrine in microdissected noradrenergic cell groups of the rabbit brain.

A. Bobik, P. Scott, C. Oddie, 1986, Journal of chromatography.

Inhibitors of hepatic mixed function oxidases. I. The metabolism of 2,6-dihydroxy-,2-hydroxy-6-methoxy- and 2,6-dimethoxyacetophenones.

G. Holder, A. Bobik, L. Wiebe, 1975, Xenobiotica; the fate of foreign compounds in biological systems.

Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

A. Vorotnikov, V. Tkachuk, R. Wait, 2012, The Biochemical journal.

Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms.

V. Tkachuk, Y. Parfyonova, A. Agrotis, 2001, Atherosclerosis.

Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque

D. Sviridov, A. Murphy, A. Dart, 2008, Circulation research.

BlOAVAILABILITY OF DIHYDROERGOTAMINE IN MAN

G. Jennings, A. Bobik, P. Little, 2006 .

Intracellular pH in vascular smooth muscle: regulation by sodium-hydrogen exchange and multiple sodium dependent HCO3- mechanisms.

P. Weissberg, P. Little, A. Bobik, 1995, Cardiovascular research.

SODIUM‐DEPENDENT, ETHYLISOPROPYLAMILORIDE‐SENSITIVE MECHANISMS REGULATE INTRACELLULAR pH IN HUMAN VASCULAR SMOOTH MUSCLE

P. Weissberg, P. Little, A. Bobik, 1990, Clinical and experimental pharmacology & physiology.

Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury.

A. Agrotis, A. Bobik, R. Khan, 2007, Cardiovascular research.

Atherosclerotic Plaque Rupture: Identifying the Straw That Breaks the Camel's Back.

K. Peter, A. Bobik, T. Kyaw, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Inert 50-nm Polystyrene Nanoparticles That Modify Pulmonary Dendritic Cell Function and Inhibit Allergic Airway Inflammation

Gabrielle T. Belz, Magdalena Plebanski, G. Belz, 2012, The Journal of Immunology.

Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly

L. Khachigian, P. Kanellakis, A. Bobik, 2007, Circulation research.

A pro-fibrotic role for interleukin-4 in cardiac pressure overload.

P. Kanellakis, A. Bobik, G. Kostolias, 2012, Cardiovascular research.

Valsalva vasoconstrictor reflex in human hypertension in after beta-adrenoreceptor blockade in conscious rabbits.

A. Tonkin, J. Uther, P. Korner, 1976, Clinical science and molecular medicine. Supplement.

No stereoselective first‐pass hepatic extraction of propranolol

G. Jennings, A. Mclean, A. Bobik, 1981, Clinical pharmacology and therapeutics.

The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes.

P. Korner, G. Jennings, M. Esler, 1987, Canadian journal of physiology and pharmacology.

alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release.

A. Bobik, W. Wolf, 1989, European journal of pharmacology.

REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING

V. Tkachuk, P. Little, A. Bobik, 1996, Clinical and experimental pharmacology & physiology.

High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice

K. Peter, M. Nishibori, I. Ahrens, 2011, Arteriosclerosis, thrombosis, and vascular biology.

B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis

H. Hosseini, B. Toh, P. Kanellakis, 2020, Frontiers in Immunology.

The preparation and purification of 3–(4‐iodophenoxy)‐1‐isopropylamino‐2‐propanol‐125I, a beta adrenergic antagonist

C. Johnston, E. Woodcock, A. Bobik, 1977 .

CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart

A. Agrotis, P. Kanellakis, A. Bobik, 2011, Journal of hypertension.

Plasmin-Independent Gelatinase B (Matrix Metalloproteinase-9) Release by Monocytes under the Influence of Urokinase

E. Kudryashova, M. Menshikov, A. Bobik, 2001, Biochemistry (Moscow).

Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis.

V. Tkachuk, M. Menshikov, A. Bobik, 2002, The Biochemical journal.

Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise.

P. Korner, G. Jennings, G. Jackman, 1979, British journal of clinical pharmacology.

Urokinase Plasminogen Activator in Injured Adventitia Increases the Number of Myofibroblasts and Augments Early Proliferation

V. Tkachuk, Y. Parfyonova, A. Bobik, 2006, Journal of Vascular Research.

Tranilast Prevents Activation of Transforming Growth Factor-&bgr; System, Leukocyte Accumulation, and Neointimal Growth in Porcine Coronary Arteries After Stenting

M. Ward, G. Jennings, A. Agrotis, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis

P. Tipping, A. Agrotis, B. Toh, 2010, The Journal of Immunology.

Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges

K. Peter, P. Tipping, B. Toh, 2017, British journal of pharmacology.

EFFECTS OF HISTAMINE BOLUS INJECTIONS AND CONTINUOUS INFUSIONS ON THE H1‐ AND H2‐RECEPTORS IN THE HINDLIMB VESSELS OF THE RABBIT

P. Korner, J. Angus, A. Bobik, 1977, Clinical and experimental pharmacology & physiology.

Human Atherosclerosis: New Participants?

A. Bobik, Y. Romanov, E. L. Soboleva, 2003 .

Intracellular pH in human arterial smooth muscle. Regulation by Na+/H+ exchange and a novel 5-(N-ethyl-N-isopropyl)amiloride-sensitive Na(+)- and HCO3(-)-dependent mechanism.

P. Little, A. Bobik, E. Cragoe, 1990, Circulation research.

Determination of prenalterol in plasma by high-performance liquid chromatography with fluorescence detection.

G. Jackman, A. Bobik, C. Oddie, 1982, Journal of chromatography.

Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development.

M. Condron, R. Dilley, A. Agrotis, 1999, Circulation.

Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.

W. Shi, M. Febbraio, A. Murphy, 2015, Cell metabolism.

The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture

K. Peter, A. Bobik, J. Noonan, 2020, British journal of pharmacology.

Low-grade inflammation and arterial stiffness in the elderly.

G. Grassi, A. Bobik, 2012, Journal of hypertension.

Vascular derived growth factors: potential role in the development of the tumour vasculature

P. Little, A. Agrotis, A. Bobik, 1997 .

Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux.

V. Tkachuk, A. Bobik, C. Neylon, 1998, Cell calcium.

Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.

P. Tipping, H. Hosseini, B. Toh, 2015, Cardiovascular research.

Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes

A. Jenkins, A. Januszewski, A. Chait, 2014 .

Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein.

P. Nestel, P. Kanellakis, A. Bobik, 2004, Atherosclerosis.

Aspirin, superoxide anions and development of hypertension.

A. Bobik, 2004, Journal of hypertension.

Cytochrome b558—Dependent NAD(P)H Oxidase—Phox Units in Smooth Muscle and Macrophages of Atherosclerotic Lesions

N. Kalinina, A. Agrotis, P. Kanellakis, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Transforming growth factor-beta 1 regulates the expression of ryanodine-sensitive Ca2+ oscillations in cardiac myocytes.

S. Bryant, P. Little, A. Bobik, 1994, Biochemical and Biophysical Research Communications - BBRC.

Foxp3+CD4+ Regulatory T-Cell Subtypes and Atherosclerosis.

B. Toh, A. Bobik, T. Kyaw, 2016, Circulation research.

A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and MicroRNA Expression Profiling

I. Haviv, K. Peter, R. Hannan, 2013, Circulation research.

Low oral bioavailability of dihydroergotamine and first‐pass extraction in patients with Orthostatic hypotension

G. Jennings, M. Esler, A. Bobik, 1981, Clinical pharmacology and therapeutics.

Reduction of first‐pass hepatic clearance of propranolol by food

A. Mclean, A. Bobik, F. Dudley, 1981, Clinical pharmacology and therapeutics.

The peripheral kinetics of norepinephrine in depressive illness.

M. Esler, G. Jackman, A. Bobik, 1982, Archives of general psychiatry.

Transforming Growth Factor-/Jl Gene Activation and Growth of Smooth Muscle From Hypertensive Rats

A. Agrotis, A. Bobik, J. Saltis, 2005 .

Transforming growth factor-beta 1 gene activation and growth of smooth muscle from

A. Bobik, J. Saltis, 2005 .

Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats.

A. Agrotis, A. Bobik, P. Bray, 1998, Hypertension.

Negatively Regulate Collagen Genes in Smooth Muscle of Hypertensive Rats Activating Growth Factors − and Receptor Tyrosine Kinase β Transforming Growth Factor

A. Agrotis, A. Bobik, P. Bray, 1998 .

DEVELOPMENTALLY REGULATED TRANSFORMING GROWTH FACTOR‐β1 ACTION ON VASCULAR SMOOTH MUSCLE GROWTH IN THE SHR

A. Agrotis, P. Kanellakis, A. Bobik, 1994, Clinical and experimental pharmacology & physiology.

Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar—Kyoto rats are growth factor dependent

A. Agrotis, A. Bobik, J. Saltis, 1993, Journal of hypertension.

Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways

A. Bobik, John Saltis, 1992, Journal of hypertension.

Enalapril Can Prevent Vascular Amplifier Development in Spontaneously Hypertensive Rats

M. Adams, A. Bobik, P. Korner, 1990, Hypertension.

VASCULAR SMOOTH MUSCLE POLYPLOIDY IN THE DEVELOPMENT AND REGRESSION OF HYPERTENSION

J. Campbell, A. Bobik, G. Campbell, 1988, Clinical and experimental pharmacology & physiology.

Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques

K. Peter, J. Mcfadyen, H. Hosseini, 2021, Thrombosis and Haemostasis.

Contrasting Effects of Urokinase and Tissue-Type Plasminogen Activators on Neointima Formation and Vessel Remodelling after Arterial Injury

Vladimir Naumov, V. Tkachuk, B. Berk, 2004, Journal of Vascular Research.

Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization

A. Vlahou, K. Peter, M. Makridakis, 2023, Communications Biology.

Cardiac beta adrenoceptors and adenylate cyclase in normotensive and renal hypertensive rabbits during changes in autonomic activity.

A. Bobik, P. Korner, 1981, Clinical and experimental hypertension.

Eplerenone Suppresses Constrictive Remodeling and Collagen Accumulation After Angioplasty in Porcine Coronary Arteries

M. Ward, J. Funder, P. Kanellakis, 2001, Circulation.

Inhibition of Fibroblast Growth Factor Receptor Signaling Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice

G. Jennings, A. Agrotis, P. Kanellakis, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity

R. Dilley, P. Kanellakis, A. Bobik, 1993, Journal of hypertension.

Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor‐like domain

V. Tkachuk, P. Little, E. Goncharova, 1997, FEBS letters.

Human Atherosclerotic Lesions : Colocalization Implicates TGF-Isoform and Receptor Expression in β Distinct Patterns of Transforming Growth Factor

M. Condron, R. Dilley, A. Agrotis, 1999 .

Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine?

R. Dilley, P. Kanellakis, A. Bobik, 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Raised Soluble P-Selectin Moderately Accelerates Atherosclerotic Plaque Progression

K. Andrews, L. Fang, J. Chin-Dusting, 2014, PloS one.

Myocarditis: causes, mechanisms, and evolving therapies

K. Peter, A. Bobik, T. Kyaw, 2023, Expert opinion on therapeutic targets.

Effects of alterations in cell phenotype and hypokalemia on sodium-potassium pump activity in rabbit vascular smooth muscle.

P. Little, A. Bobik, 1985, Clinical and experimental hypertension. Part A, Theory and practice.

A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.

A. Husband, P. Nestel, A. Agrotis, 2009, Atherosclerosis.

EFFECTS OF INTRACELLULAR Ca2+ CHELATING ON NORADRENALINE RELEASE IN NORMOXIC AND ANOXIC HEARTS

A. Dart, M. Esler, A. Bobik, 1997, Clinical and experimental pharmacology & physiology.

GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury.

T. Collins, L. Khachigian, A. Bobik, 1999, Circulation research.

Norepinephrine Kinetics in Essential Hypertension

P. Korner, G. Jennings, M. Esler, 1981, Hypertension.

Differential forskolin activation of rat heart and lung adenylate cyclase. Dependence on membrane-protein interactions.

G. Jackman, A. Bobik, 1989, Biochemical pharmacology.

Forskolin-mediated activation of cardiac, liver and lung adenylate cyclase in the rat. Relation to [3H]forskolin binding sites.

G. Jackman, A. Bobik, 1986, Biochemical pharmacology.

EFFECTS OF FIVE NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON THE RENAL AND SYSTEMIC RESPONSES TO ARACHIDONATE IN CONSCIOUS DOGS

W. P. Anderson, A. Bobik, 1987, Clinical and experimental pharmacology & physiology.

Cardiovascular hypertrophy in one‐kidney, one clip renal hypertensive rats: a role for angiotensin II?

J. Bertram, M. Black, A. Bobik, 1994, Journal of hypertension.

Transforming growth factor-beta, cell signaling and cardiovascular disorders.

N. Kalinina, A. Agrotis, A. Bobik, 2005, Current vascular pharmacology.

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension

C. Sobey, Antony Vinh, A. Bobik, 2023, Frontiers in Cardiovascular Medicine.

Vascular hypertrophy in renal hypertensive spontaneously hypertensive rats.

R. Dilley, P. Kanellakis, A. Bobik, 1994, Hypertension.

Scientific Contributions Vascular Hypertrophy in Renal Hypertensive Spontaneously Hypertensive Rats

R. Dilley, P. Kanellakis, A. Bobik, 2005 .

Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.

G. Jennings, G. Jackman, A. Bobik, 1986, Hypertension.

Mechanism of isoprenaline induced desensitization of rabbit aortic smooth muscle beta-adrenoceptor responses.

P. Little, J. Campbell, A. Bobik, 1984, Clinical and experimental pharmacology & physiology.

DIFFERING NORADRENALINE KINETICS IN ESSENTIAL HYPERTENSION AND DEPRESSIVE ILLNESS, TWO DISEASES IN WHICH THE PLASMA CONCENTRATION OF NORADRENALINE IS SOMETIMES ELEVATED

P. Korner, G. Jennings, M. Esler, 1981, Clinical and Experimental Pharmacology and Physiology.

DRUG ANALYSIS IN THE OVERDOSED PATIENT ITS APPLICATION TO CLINICAL TOXICOLOGY

A. Mclean, A. Bobik, 1977, Medical Journal of Australia.

Cardiovascular complications due to pheniramine overdosage.

A. Mclean, A. Bobik, 1976, Australian and New Zealand journal of medicine.

Thrombosis and Haemostasis Pharmacological inhibition of Factor XIIa attenuates abdominal aortic an- eurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques

J. Mcfadyen, P. Kanellakis, A. Bobik, 2021 .

Renin‐dependent hypertension induces smooth muscle polyploidy in large and small vessels

R. Dilley, M. Black, A. Bobik, 1993, Journal of Hypertension - Supplement.

Study of noradrenaline uptake and spillover to plasma in normal subjects and patients with essential hypertension.

M. Esler, G. Jackman, A. Bobik, 1980, Progress in biochemical pharmacology.

Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.

P. Little, A. Agrotis, A. Bobik, 1993, European journal of pharmacology.

PLASMA LEVELS FOLLOWING SINGLE INTRAVENOUS, ORAL AND MULTIPLE ORAL DOSAGE IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS

A. Mclean, A. Bobik, A. Barnett, 1977 .

Central and peripheral autonomic mechanisms involved in the circulatory actions of methyldopa.

P. Korner, A. Bobik, G. Head, 1984, Hypertension.

Interferon regulatory factor 4 a master regulator of hypertensive kidney fibrosis and inflammation?

A. Bobik, T. Kyaw, G. Drummond, 2023, Journal of hypertension.

Proliferation of Neointimal Smooth Muscle Cells after Arterial Injury

G. Jennings, R. Hannan, A. Agrotis, 2004, Journal of Biological Chemistry.

Association of constipation with increased risk of hypertension and cardiovascular events in elderly Australian patients

C. Sobey, Antony Vinh, A. Bobik, 2023, Scientific reports.

The effects of endogenous phospholipase A2 activation on beta adrenoceptor function in cardiac cells.

P. Little, J. Campbell, A. Bobik, 1983, Journal of molecular and cellular cardiology.